← Back to patent-cliff list
CAS 1995868-17-1
2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)-1-(4-hydroxy-3-(hydroxymethyl)phenyl)ethanone
Codes：SALM-023
Application context (from source-drug indications)
哮喘布地奈德/昔萘酸沙美特罗
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 布地奈德/昔萘酸沙美特罗Budesonide/Salmeterol xinafoate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(4-((6-bromohexyl)oxy)butyl)benzene→2-acetoxy-5-(2-(benzylamino)acetyl)benzyl acetate→2-acetoxy-5-(2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)acetyl)benzyl acetate→2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)-1-(4-hydroxy-3-(hydroxymethyl)phenyl)ethanone→4-(2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.